“hatteras-venture-partners” Archives

in
Entry Author Date Location
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Trefoil Therapeutics Raises $28M and Eyes the Clinic for Cornea Drug 07/16/19 San Diego
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
Hatteras Launches New Fund With $94M for Life Science Investments 04/15/19 Raleigh Durham
Kymera Adds $65M in New Funding and Eyes First Clinical Test 11/13/18 Boston
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections 10/22/18 San Diego
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
AgTech Accelerator Brings Biopharma Models to Ag Investing Strategy 11/06/17 Raleigh Durham
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
HistoSonics Aims To Move Forward After Raising $8.5M, Naming New CEO 04/24/17 Detroit Ann Arbor
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI 01/09/17 Boston
G1 Therapeutics Hauls in $47M for Lung, Breast Cancer Trials 05/12/16 Raleigh Durham
Viamet Revisits IPO Plans, This Time With More Data 04/11/16 Raleigh Durham
Bivarus Obtains $2,000,000 New Financing 03/23/16 Raleigh Durham
What Connect NC Means for AgBio Research, & More Innovation News 03/14/16 Raleigh Durham
Improving Odds for Women in Tech? Take Notes from Biotech 02/04/16 Boston
Medfusion Secures $3,000,000 New Financing Round 09/02/15 Raleigh Durham
Medfusion Lands $3M for Patient-Focused Software Push 09/01/15 Raleigh Durham
Hatteras Venture Closes $90M Life Sciences, Health IT Fund 08/24/15 Raleigh Durham
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Curoverse Begins Trial Run for Open Source Genomics Tool 04/14/15 Boston
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
As Promised, LTI Pulls In Big Series A to Advance Parkinson’s Drug 02/03/15 Boston
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
MoneyTree Reports $121M in MI Venture Deals Last Quarter 07/22/14 Detroit Ann Arbor
Curoverse Obtains $1,500,000 Seed Financing Round 12/19/13 Boston
Curoverse Gets $1.5M to Develop Open Source Genomics Tool 12/18/13 Boston
Page 1 of 2 next page »